Targeting the Wnt/β-catenin signaling pathway in cancer

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• The Wnt/β-catenin signaling pathway is crucial for cancer stem cell renewal, proliferation, and differentiation.
• Aberrant Wnt/β-catenin signaling drives tumorigenesis and influences response to cancer therapies.
• Targeting this pathway presents a significant therapeutic opportunity in oncology.

Purpose of the Study:

• To provide a comprehensive overview of the latest advancements in Wnt/β-catenin signaling pathway-targeted therapies for various cancer types.
• To outline current approaches and future perspectives in developing targeted agents.
• To inform innovative strategies for personalized cancer treatment.

Main Methods:

• This study conducted a scoping review of preclinical and clinical investigations.
• Key components of the Wnt/β-catenin cascade, including ligand/receptor interactions and protein complexes, were analyzed.
• Progress on inhibitors, antagonists, and activators of the pathway was evaluated.

Main Results:

• The Wnt/β-catenin pathway is a validated target in cancer therapy, with multiple intervention points identified.
• Preclinical and clinical studies are exploring various agents to modulate this pathway.
• Understanding pathway dynamics aids in rationalizing targeted treatment strategies.

Conclusions:

• Targeted therapies modulating the Wnt/β-catenin pathway hold significant potential for cancer treatment.
• Further research is needed to identify precise, safe, and effective agents for optimal clinical benefit.
• Personalized treatment strategies can be developed by better understanding pathway modulation.